Trial intelligence / Profile preview

Denosumab vs alendronate for coronary artery calcification in osteoporosis with coronary artery disease

jRCT1031190025Completed

Start
Dec 2019
Modality
Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Randomised trial in osteoporosis comparing Denosumab arm with Alendronate arm (2 arms). Primary endpoint: Percent change in coronary artery calcification score. Started Dec 2019; status: completed.

02

Drugs

denosumabalendronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on jRCT1031190025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031190025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call